The independent source for health policy research, polling, and news.
641 - 660 of 1,591 Results
Despite his lack of front-line experience, Democrats see the California attorney general as an important ally to shepherd a progressive agenda on the Affordable Care Act, Medicaid, reproductive health services and immigration.
Rather than prosecuting their case against Supreme Court nominee Amy Coney Barrett, Democrats on the Senate Judiciary Committee are refighting the war that won them seats in 2018 — banging on Republicans for trying to eliminate the Affordable Care Act.
President Donald Trump’s executive order says that people with preexisting conditions can get affordable insurance. But it doesn’t explain how.
Like almost a quarter of the 989 people killed by police in the U.S. in the past 12 months, Ricardo Muñoz had a serious mental illness. "Instead of a cop just being there, there should have been other responders," his sister says.
Much like President Barack Obama, a President Biden could find his health policies initially sidelined by economic issues — in his case, caused by the pandemic.
How will health issues affect voter choices? What will happen if President Donald Trump is reelected or the White House goes to Joe Biden? In this special election preview episode, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
As coronavirus cases surge, state officials can’t afford to wait for a new president to take office before taking action. But some governors’ initiatives seem to be little more than policy tweaks or symbolic gestures.
If Democrat Joe Biden is successful in his bid for the presidency but the Senate remains in GOP control, Democrats’ plans for major changes in health care may be curbed.
California has more at stake than any other state should the U.S. Supreme Court strike down the Affordable Care Act. Millions of people could lose their health coverage and the state could lose billions in federal money each year.
President Donald Trump wants to send seniors $200 apiece. Beyond the legal and logistical problems, health care experts point out it does little to help someone with even typical prescription costs.
President Donald Trump this week issued a prescription drug pricing order unlikely to lower drug prices, and he contradicted comments by his director of the Centers for Disease Control and Prevention on the need for mask-wearing and predictions for vaccine availability. Meanwhile, scandals erupted at the CDC, the Centers for Medicare & Medicaid Services and the Food and Drug Administration. And the number of people without health insurance grew in 2019, reported the Census Bureau, even while the economy soared. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Tuesday night's presidential debate offered voters their first side-by-side comparison of the candidates, President Donald Trump and former Vice President Joe Biden.
About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.
This statement is taken from a video in which a group of doctors air unproven conspiracy theories about the coronavirus. Dr. Immanuel's claims were among the most inaccurate. And, before it was removed from social media platforms, thee video was viewed millions of times. President Donald Trump retweeted it.
President Donald Trump has been heralding drugmakers as “great companies.” Yet in the final stretch of the presidential campaign, Trump is not feeling the love in pharma contributions. Former Vice President Joe Biden is, even though his proposed policies could dent the industry’s profitability.
Democrats are favored to win both chambers of Congress after years of campaign-trail promises about health care. But their margin in the Senate could be slim, making it difficult to pass major health care legislation. And they still must heal some rifts within the caucus about how far they can push overhaul efforts.
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.
Sen. Kamala Harris accepted the Democratic nomination for vice president amid strong arguments against Donald Trump.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
The death of Supreme Court Justice Ruth Bader Ginsburg is giving new life to the latest constitutional challenge to the Affordable Care Act. It also places anti-abortion activists on the cusp of a court majority large enough to ensure the rollback of the right to abortion and, possibly, some types of birth control. Meanwhile, Health and Human Services Secretary Alex Azar tries to centralize power at the sprawling department plagued by miscommunications and scandals. Anna Edney of Bloomberg News, Kimberly Leonard of Business Insider and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Sarah Jane Tribble about her new podcast, “Where It Hurts,” debuting Sept. 29.
© 2026 KFF